BIB
Ultra Nasdaq Biotechnology
Investment Objective
ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.
Documents & Downloads
You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)
Performance
Daily Return during Q3 2024
Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.
Total Return
Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
---|---|---|---|---|---|---|---|---|---|---|
BIB Market Price | 11.18% | -2.89% | 23.84% | -1.61% | 7.51% | -12.74% | 5.15% | 3.36% | 15.31% | 04/07/2010 |
BIB NAV | 11.23% | -2.98% | 23.86% | -1.78% | 7.49% | -12.75% | 5.15% | 3.35% | 15.30% | 04/07/2010 |
Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
---|---|---|---|---|---|---|---|---|---|---|
BIB Market Price | -0.38% | 0.93% | 20.13% | 0.93% | 6.36% | -11.66% | 0.77% | 3.74% | 15.72% | 04/07/2010 |
BIB NAV | -0.40% | 0.82% | 19.90% | 0.82% | 6.23% | -11.64% | 0.79% | 3.73% | 15.72% | 04/07/2010 |
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.
About the Fund
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/8/10
- Gross Expense Ratio 1.15%
- Net Expense Ratio 0.95%
- NAV Calculation Time 4:00 p.m. ET
Price
as of 7/02/2024- NAV $57.96
- NAV Change $-1.31
- Market Price $58.07
- Market Price Change $-1.08
- Trading Volume (M) 16,548
- 30-Day Median Bid Ask Spread 0.00%
- View Premium / Discount
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/8/10
- Expense Ratio 0.95%
- Gross Expense Ratio 1.15%
- NAV Calculation Time 4:00 p.m. ET
Price
as of 7/02/2024- NAV $57.96
- NAV Change $-1.31
- Market Price $58.07
- Market Price Change $-1.08
- Trading Volume (M) 16,548
- 30-Day Median Bid Ask Spread 0.00%
- View Premium / Discount
The expense ratio above has a contractual waiver ending 9/30/24.
Exposures
Index as of 3/28/2024
Holdings
as of 7/02/2024
Exposure Weight | Ticker | Description | Exposure Value (Notional + GL) |
Market Value | Shares/Contracts | SEDOL Number |
---|---|---|---|---|---|---|
47.89% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 40,253,542 | -- | 8,951 | -- |
36.96% | -- | NASDAQ BIO INDEX SWAP BNP | 31,061,470 | -- | 6,907 | -- |
23.61% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 19,845,702 | -- | 4,413 | -- |
7.07% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 5,940,669 | -- | 1,321 | -- |
6.47% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 5,436,994 | -- | 1,209 | -- |
5.81% | REGN | REGENERON PHARMACEUTICALS | -- | $4,883,785.50 | 4,675 | 2730190 |
5.80% | GILD | GILEAD SCIENCES INC | -- | $4,876,509.60 | 71,294 | 2369174 |
5.67% | VRTX | VERTEX PHARMACEUTICALS INC | -- | $4,767,648.14 | 10,063 | 2931034 |
5.54% | AMGN | AMGEN INC | -- | $4,655,645.37 | 14,981 | 2023607 |
4.74% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 3,984,431 | -- | 886 | -- |
3.65% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC | 3,071,519 | -- | 683 | -- |
3.25% | MRNA | MODERNA INC | -- | $2,730,423.61 | 23,323 | BGSXTS3 |
2.69% | AZN | ASTRAZENECA PLC-SPONS ADR | -- | $2,260,734.36 | 29,364 | 2989044 |
2.45% | BIIB | BIOGEN INC | -- | $2,056,634.16 | 8,988 | 2455965 |
2.30% | ALNY | ALNYLAM PHARMACEUTICALS INC | -- | $1,933,586.49 | 7,809 | B00FWN1 |
1.23% | ILMN | ILLUMINA INC | -- | $1,037,585.34 | 9,834 | 2613990 |
1.15% | BMRN | BIOMARIN PHARMACEUTICAL INC | -- | $963,782.84 | 11,722 | 2437071 |
1.07% | SRPT | SAREPTA THERAPEUTICS INC | -- | $898,831.80 | 5,829 | B8DPDT7 |
1.03% | UTHR | UNITED THERAPEUTICS CORP | -- | $868,399.95 | 2,739 | 2430412 |
1.02% | ARGX | ARGENX SE - ADR | -- | $861,399.22 | 1,978 | BDVLM39 |
1.02% | NBIX | NEUROCRINE BIOSCIENCES INC | -- | $854,087.88 | 6,212 | 2623911 |
1.00% | SNY | SANOFI-ADR | -- | $844,110.60 | 17,390 | 2964557 |
0.97% | INCY | INCYTE CORP | -- | $818,902.50 | 13,875 | 2471950 |
0.92% | MEDP | MEDPACE HOLDINGS INC | -- | $773,655.46 | 1,913 | BDCBC61 |
0.91% | VTRS | VIATRIS INC | -- | $766,667.58 | 73,506 | BMWS3X9 |
0.86% | RPRX | ROYALTY PHARMA PLC- CL A | -- | $720,680.36 | 27,847 | BMVP7Y0 |
0.76% | INSM | INSMED INC | -- | $641,968.50 | 9,953 | 2614487 |
0.61% | PCVX | VAXCYTE INC | -- | $510,895.02 | 6,717 | BKPVGH6 |
0.58% | ASND | ASCENDIS PHARMA A/S - ADR | -- | $487,301.52 | 3,576 | BV9G6B8 |
0.57% | ROIV | ROIVANT SCIENCES LTD | -- | $481,588.80 | 45,605 | BMW4NZ9 |
0.57% | BNTX | BIONTECH SE-ADR | -- | $476,734.28 | 6,053 | BK6H543 |
0.53% | ITCI | INTRA-CELLULAR THERAPIES INC | -- | $446,743.72 | 6,518 | BHCB0P4 |
0.51% | BPMC | BLUEPRINT MEDICINES CORP | -- | $426,651.76 | 3,866 | BWY52P3 |
0.49% | JAZZ | JAZZ PHARMACEUTICALS PLC | -- | $409,010.28 | 3,892 | B4Q5ZN4 |
0.48% | IONS | IONIS PHARMACEUTICALS INC | -- | $406,756.54 | 9,011 | BDJ0LS6 |
0.48% | HALO | HALOZYME THERAPEUTICS INC | -- | $403,320.60 | 7,862 | 2975098 |
0.47% | EXEL | EXELIXIS INC | -- | $398,323.45 | 17,983 | 2576941 |
0.46% | CYTK | CYTOKINETICS INC | -- | $388,212.36 | 7,079 | BBBSBJ5 |
0.45% | RVMD | REVOLUTION MEDICINES INC | -- | $380,715.30 | 10,185 | BL71K91 |
0.45% | BGNE | BEIGENE LTD-ADR | -- | $379,831.27 | 2,639 | BYYWPW6 |
0.43% | MDGL | MADRIGAL PHARMACEUTICALS INC | -- | $357,517.72 | 1,316 | BD59BS7 |
0.39% | SMMT | SUMMIT THERAPEUTICS INC | -- | $326,753.44 | 43,336 | BMTVQS7 |
0.37% | KRYS | KRYSTAL BIOTECH INC | -- | $313,126.43 | 1,763 | BD6JX35 |
0.34% | BBIO | BRIDGEBIO PHARMA INC | -- | $287,760.32 | 11,552 | BK1KWG8 |
0.33% | CRSP | CRISPR THERAPEUTICS AG | -- | $278,428.83 | 5,242 | BDHF4K6 |
0.32% | NUVL | NUVALENT INC-A | -- | $266,450.00 | 3,650 | BMVBZD3 |
0.31% | IBRX | IMMUNITYBIO INC | -- | $263,848.92 | 42,694 | BNSP0B8 |
0.31% | APLS | APELLIS PHARMACEUTICALS INC | -- | $262,070.16 | 7,492 | BYTQ6X1 |
0.30% | ALKS | ALKERMES PLC | -- | $252,712.93 | 10,447 | B3P6D26 |
0.28% | IMVT | IMMUNOVANT INC | -- | $239,130.84 | 9,017 | BJRFSB7 |
0.28% | AXSM | AXSOME THERAPEUTICS INC | -- | $231,422.76 | 2,932 | BYZR4X4 |
0.27% | RNA | AVIDITY BIOSCIENCES INC | -- | $229,075.20 | 5,904 | BMWHPY1 |
0.27% | LEGN | LEGEND BIOTECH CORP-ADR | -- | $225,623.82 | 5,043 | BMX9K07 |
0.26% | CRNX | CRINETICS PHARMACEUTICALS IN | -- | $221,688.72 | 4,868 | BDD19F8 |
0.26% | GH | GUARDANT HEALTH INC | -- | $218,083.98 | 7,554 | BFXC911 |
0.26% | MRUS | MERUS NV | -- | $217,085.01 | 4,089 | BZBY005 |
0.25% | RARE | ULTRAGENYX PHARMACEUTICAL IN | -- | $210,206.72 | 5,132 | BJ62Z18 |
0.25% | DYN | DYNE THERAPEUTICS INC | -- | $209,701.80 | 6,052 | BN15WD1 |
0.23% | ARWR | ARROWHEAD PHARMACEUTICALS IN | -- | $193,386.96 | 7,668 | BYQBFJ8 |
0.23% | DNLI | DENALI THERAPEUTICS INC | -- | $191,398.96 | 8,804 | BD2B4V0 |
0.21% | FOLD | AMICUS THERAPEUTICS INC | -- | $180,117.10 | 18,286 | B19FQ48 |
0.21% | ACLX | ARCELLX INC | -- | $175,884.75 | 3,303 | BPCJ1Q2 |
0.20% | SWTX | SPRINGWORKS THERAPEUTICS INC | -- | $170,472.98 | 4,574 | BGMGM89 |
0.20% | XENE | XENON PHARMACEUTICALS INC | -- | $170,369.60 | 4,660 | BRJ3GY4 |
0.20% | TWST | TWIST BIOSCIENCE CORP | -- | $170,115.40 | 3,595 | BGKG6G7 |
0.19% | ADMA | ADMA BIOLOGICS INC | -- | $163,134.00 | 14,310 | B9NSBM2 |
0.19% | ACAD | ACADIA PHARMACEUTICALS INC | -- | $161,552.16 | 10,199 | 2713317 |
0.19% | RYTM | RHYTHM PHARMACEUTICALS INC | -- | $159,367.76 | 3,764 | BF2YWG4 |
0.19% | IDYA | IDEAYA BIOSCIENCES INC | -- | $157,539.84 | 4,672 | BK0VHF6 |
0.18% | GERN | GERON CORP | -- | $152,688.72 | 36,616 | 2370381 |
0.18% | AGIO | AGIOS PHARMACEUTICALS INC | -- | $147,385.25 | 3,505 | BCBVTX1 |
0.17% | PTCT | PTC THERAPEUTICS INC | -- | $143,896.65 | 4,735 | B17VCN9 |
0.16% | MYGN | MYRIAD GENETICS INC | -- | $138,284.60 | 5,585 | 2614153 |
0.16% | VCEL | VERICEL CORP | -- | $135,255.07 | 3,001 | BSBMN89 |
0.16% | IOVA | IOVANCE BIOTHERAPEUTICS INC | -- | $133,543.48 | 17,276 | BF0DMK7 |
0.16% | NTLA | INTELLIA THERAPEUTICS INC | -- | $131,925.40 | 5,956 | BYZM6C2 |
0.16% | FTRE | FORTREA HOLDINGS INC | -- | $131,352.20 | 5,519 | BRXYZ57 |
0.15% | JANX | JANUX THERAPEUTICS INC | -- | $125,799.30 | 3,201 | BMFX8Y7 |
0.15% | PTGX | PROTAGONIST THERAPEUTICS INC | -- | $125,250.39 | 3,621 | BDCBCD8 |
0.14% | VERA | VERA THERAPEUTICS INC | -- | $117,958.61 | 3,377 | BL55460 |
0.14% | GPCR | STRUCTURE THERAPEUTICS INC | -- | $117,080.79 | 3,023 | BQS9486 |
0.14% | BEAM | BEAM THERAPEUTICS INC | -- | $114,678.17 | 5,081 | BK6L288 |
0.14% | KYMR | KYMERA THERAPEUTICS INC | -- | $114,473.36 | 3,788 | BMPRZV5 |
0.13% | AMPH | AMPHASTAR PHARMACEUTICALS IN | -- | $113,454.02 | 3,019 | BNFWZS4 |
0.13% | NVAX | NOVAVAX INC | -- | $112,423.96 | 8,668 | BJDQXG4 |
0.13% | NVCR | NOVOCURE LTD | -- | $111,602.40 | 6,643 | BYSS4X4 |
0.13% | RCKT | ROCKET PHARMACEUTICALS INC | -- | $110,906.46 | 5,607 | BDFKQ07 |
0.13% | SNDX | SYNDAX PHARMACEUTICALS INC | -- | $108,382.36 | 5,246 | BN7Q7R7 |
0.13% | MORF | MORPHIC HOLDING INC | -- | $107,040.16 | 3,422 | BK8M4J4 |
0.13% | APGE | APOGEE THERAPEUTICS INC | -- | $105,994.54 | 2,774 | BM9HHL5 |
0.13% | EWTX | EDGEWISE THERAPEUTICS INC | -- | $105,979.08 | 5,766 | BKY5JZ8 |
0.13% | HRMY | HARMONY BIOSCIENCES HOLDINGS | -- | $105,180.00 | 3,506 | BKSGZN7 |
0.12% | ARVN | ARVINAS INC | -- | $104,991.25 | 4,225 | BDZ30Q0 |
0.12% | RXRX | RECURSION PHARMACEUTICALS-A | -- | $101,786.56 | 14,216 | BM9FJ13 |
0.12% | VCYT | VERACYTE INC | -- | $100,347.20 | 4,720 | BFTWZY0 |
0.12% | MIRM | MIRUM PHARMACEUTICALS INC | -- | $98,008.80 | 2,910 | BJDX8Y8 |
0.12% | KURA | KURA ONCOLOGY INC | -- | $96,787.74 | 4,703 | BYZD465 |
0.11% | AKRO | AKERO THERAPEUTICS INC | -- | $95,540.22 | 4,269 | BK7Y2V9 |
0.11% | KROS | KEROS THERAPEUTICS INC | -- | $95,380.68 | 2,228 | BM7V485 |
0.11% | LGND | LIGAND PHARMACEUTICALS | -- | $94,032.11 | 1,109 | 2501578 |
0.11% | DVAX | DYNAVAX TECHNOLOGIES CORP | -- | $89,537.48 | 8,081 | BRJZSK0 |
0.10% | SUPN | SUPERNUS PHARMACEUTICALS INC | -- | $87,463.38 | 3,394 | B72ZBG4 |
0.10% | MNKD | MANNKIND CORP | -- | $84,554.30 | 16,810 | BF081J4 |
0.10% | BCRX | BIOCRYST PHARMACEUTICALS INC | -- | $83,447.00 | 12,740 | 2100362 |
0.10% | AVDL | AVADEL PHARMACEUTICALS | -- | $82,423.26 | 5,934 | BDGMC59 |
0.10% | ANIP | ANI PHARMACEUTICALS INC | -- | $81,056.16 | 1,294 | BCDWBX6 |
0.10% | IMCR | IMMUNOCORE HOLDINGS PLC-ADR | -- | $80,109.60 | 2,302 | BLCD809 |
0.09% | ARDX | ARDELYX INC | -- | $76,264.32 | 14,444 | BN89V40 |
0.09% | VIR | VIR BIOTECHNOLOGY INC | -- | $74,331.15 | 8,399 | BK4PZ38 |
0.09% | SANA | SANA BIOTECHNOLOGY INC | -- | $73,155.90 | 13,674 | BMFJJ97 |
0.09% | DAWN | DAY ONE BIOPHARMACEUTICALS I | -- | $72,616.70 | 5,395 | BLB0YH0 |
0.08% | XNCR | XENCOR INC | -- | $69,515.82 | 3,807 | BGCYWN8 |
0.08% | NRIX | NURIX THERAPEUTICS INC | -- | $69,302.73 | 3,661 | BMVLGP2 |
0.08% | PRTA | PROTHENA CORP PLC | -- | $67,776.36 | 3,324 | B91XRN2 |
0.08% | VRNA | VERONA PHARMA PLC - ADR | -- | $66,524.38 | 4,303 | BYWPZK5 |
0.08% | ARQT | ARCUTIS BIOTHERAPEUTICS INC | -- | $66,457.80 | 7,146 | BKX9VD3 |
0.08% | FDMT | 4D MOLECULAR THERAPEUTICS IN | -- | $65,691.36 | 3,192 | BKLXFX5 |
0.08% | PCRX | PACIRA BIOSCIENCES INC | -- | $65,332.02 | 2,873 | B3X26D8 |
0.08% | COLL | COLLEGIUM PHARMACEUTICAL INC | -- | $64,720.80 | 2,020 | BX7RSN3 |
0.08% | GMAB | GENMAB A/S -SP ADR | -- | $64,441.20 | 2,588 | BBC9WC7 |
0.08% | TARS | TARSUS PHARMACEUTICALS INC | -- | $64,246.60 | 2,332 | BMH5RL1 |
0.08% | OCUL | OCULAR THERAPEUTIX INC | -- | $63,874.16 | 9,562 | BNZB1X8 |
0.08% | INVA | INNOVIVA INC | -- | $63,607.50 | 3,855 | BDDXF67 |
0.08% | IRON | DISC MEDICINE INC | -- | $63,512.12 | 1,526 | BMGJZJ8 |
0.07% | ELVN | ENLIVEN THERAPEUTICS INC | -- | $63,016.80 | 2,904 | BMFD115 |
0.07% | IRWD | IRONWOOD PHARMACEUTICALS INC | -- | $61,030.64 | 9,812 | B3MZ6K5 |
0.07% | CGEM | CULLINAN THERAPEUTICS INC | -- | $58,030.98 | 3,558 | BM90J52 |
0.07% | MRVI | MARAVAI LIFESCIENCES HLDGS-A | -- | $56,081.16 | 8,199 | BMCWKZ2 |
0.07% | ZLAB | ZAI LAB LTD-ADR | -- | $55,184.49 | 3,177 | BD9GVY0 |
0.06% | TNGX | TANGO THERAPEUTICS INC | -- | $53,452.48 | 6,595 | BP2P6L0 |
0.06% | RLAY | RELAY THERAPEUTICS INC | -- | $53,015.18 | 8,194 | BN2R582 |
0.06% | SPRY | ARS PHARMACEUTICALS INC | -- | $51,804.12 | 5,982 | BMCR7V2 |
0.06% | ABCL | ABCELLERA BIOLOGICS INC | -- | $50,281.04 | 18,152 | BL53SR3 |
0.06% | GRFS | GRIFOLS SA-ADR | -- | $49,102.12 | 7,531 | B8K7T65 |
0.06% | COGT | COGENT BIOSCIENCES INC | -- | $48,632.48 | 5,902 | BLR6XK8 |
0.06% | AUPH | AURINIA PHARMACEUTICALS INC | -- | $47,941.47 | 8,829 | BFWLC09 |
0.06% | CVAC | CUREVAC NV | -- | $46,248.98 | 13,847 | BN4RD42 |
0.05% | ETNB | 89BIO INC | -- | $46,162.40 | 6,074 | BK1K484 |
0.05% | -- | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC COMMON STOCK USD 0.000273 | -- | $45,903.60 | 2,488 | -- |
0.05% | HROW | HARROW INC | -- | $45,557.25 | 2,185 | BHNDW86 |
0.05% | BCYC | BICYCLE THERAPEUTICS PLC-ADR | -- | $43,938.58 | 2,218 | BKDQKM6 |
0.05% | AUTL | AUTOLUS THERAPEUTICS PLC | -- | $41,617.94 | 12,313 | BFMLGR4 |
0.05% | EOLS | EVOLUS INC | -- | $41,200.90 | 3,865 | BDRJH21 |
0.05% | PETQ | PETIQ INC | -- | $41,181.57 | 1,823 | BDH65C8 |
0.05% | ANAB | ANAPTYSBIO INC | -- | $40,386.78 | 1,687 | BDRW1L7 |
0.05% | SAGE | SAGE THERAPEUTICS INC | -- | $40,196.30 | 3,715 | BP4GNK9 |
0.05% | PLRX | PLIANT THERAPEUTICS INC | -- | $39,474.40 | 3,724 | BMDWW66 |
0.05% | WVE | WAVE LIFE SCIENCES LTD | -- | $39,457.98 | 7,559 | BYZG9R0 |
0.05% | PRME | PRIME MEDICINE INC | -- | $39,119.52 | 7,409 | BPBJFM7 |
0.05% | TVTX | TRAVERE THERAPEUTICS INC | -- | $38,023.00 | 4,700 | BLFGJD5 |
0.04% | SRRK | SCHOLAR ROCK HOLDING CORP | -- | $37,570.12 | 4,924 | BFZQ0L8 |
0.04% | HUMA | HUMACYTE INC | -- | $37,563.61 | 7,351 | BMYTJP4 |
0.04% | ERAS | ERASCA INC | -- | $37,212.80 | 16,040 | BNLYBF3 |
0.04% | MLYS | MINERALYS THERAPEUTICS INC | -- | $37,055.85 | 3,065 | BP9N0G0 |
0.04% | PHAT | PHATHOM PHARMACEUTICALS INC | -- | $37,033.25 | 3,613 | BJLKVS6 |
0.04% | SVRA | SAVARA INC | -- | $36,679.00 | 8,530 | BYXGN81 |
0.04% | ZYME | ZYMEWORKS INC | -- | $36,666.00 | 4,365 | BPCQZY9 |
0.04% | ABUS | ARBUTUS BIOPHARMA CORP | -- | $36,461.37 | 11,649 | BZ0QMB7 |
0.04% | CSTL | CASTLE BIOSCIENCES INC | -- | $36,227.04 | 1,704 | BKLCWZ3 |
0.04% | OLMA | OLEMA PHARMACEUTICALS INC | -- | $35,935.32 | 3,452 | BMZ4LN0 |
0.04% | ARCT | ARCTURUS THERAPEUTICS HOLDIN | -- | $35,721.24 | 1,663 | BKC9SX3 |
0.04% | LXRX | LEXICON PHARMACEUTICALS INC | -- | $35,705.60 | 22,316 | BWFZX59 |
0.04% | SIGA | SIGA TECHNOLOGIES INC | -- | $34,242.00 | 4,390 | 2107437 |
0.04% | URGN | UROGEN PHARMA LTD | -- | $33,777.34 | 2,231 | BZ7PJQ1 |
0.04% | ITOS | ITEOS THERAPEUTICS INC | -- | $33,212.00 | 2,300 | BMWXFT4 |
0.04% | HCM | HUTCHMED CHINA-ADR | -- | $32,976.30 | 1,915 | BYXV9H7 |
0.04% | RGNX | REGENXBIO INC | -- | $32,680.00 | 3,040 | BZ0G875 |
0.04% | GLPG | GALAPAGOS NV-SPON ADR | -- | $31,801.70 | 1,255 | B292NQ7 |
0.04% | REPL | REPLIMUNE GROUP INC | -- | $31,730.67 | 3,791 | BDDVW37 |
0.04% | CNTA | CENTESSA PHARMACEUTICALS-ADR | -- | $31,379.06 | 3,578 | BLB0YQ9 |
0.04% | ORIC | ORIC PHARMACEUTICALS INC | -- | $31,298.24 | 4,162 | BKVDFF7 |
0.04% | THRD | THIRD HARMONIC BIO INC | -- | $30,942.72 | 2,528 | BNNPQY8 |
0.04% | YMAB | Y-MABS THERAPEUTICS INC | -- | $30,801.33 | 2,709 | BG31GH0 |
0.04% | ADPT | ADAPTIVE BIOTECHNOLOGIES | -- | $30,653.52 | 9,096 | BJ5FZ74 |
0.04% | KALV | KALVISTA PHARMACEUTICALS INC | -- | $29,972.04 | 2,604 | BD06CS0 |
0.03% | ALLO | ALLOGENE THERAPEUTICS INC | -- | $27,840.24 | 12,889 | BFZNYB7 |
0.03% | TERN | TERNS PHARMACEUTICALS INC | -- | $26,826.24 | 3,992 | BMDJ0C9 |
0.03% | OABI | OMNIAB INC | -- | $26,644.20 | 7,260 | BN13S71 |
0.03% | VERV | VERVE THERAPEUTICS INC | -- | $25,910.00 | 5,182 | BNKGXX2 |
0.03% | ALEC | ALECTOR INC | -- | $25,818.66 | 5,949 | BJ4LDC4 |
0.03% | EYPT | EYEPOINT PHARMACEUTICALS INC | -- | $25,760.16 | 3,216 | BMGS7L1 |
0.03% | VYGR | VOYAGER THERAPEUTICS INC | -- | $25,487.22 | 3,358 | BY7RB53 |
0.03% | SLRN | ACELYRIN INC | -- | $25,185.56 | 6,113 | BQPF874 |
0.03% | TBPH | THERAVANCE BIOPHARMA INC | -- | $24,976.64 | 3,002 | BMNDK09 |
0.03% | TSHA | TAYSHA GENE THERAPIES INC | -- | $24,937.20 | 11,545 | BNC1BX1 |
0.03% | -- | GRAIL INC COMMON STOCK USD | -- | $24,666.95 | 1,639 | -- |
0.03% | MXCT | MAXCYTE INC | -- | $24,005.16 | 6,453 | BKMQF66 |
0.03% | LYEL | LYELL IMMUNOPHARMA INC | -- | $23,762.87 | 15,737 | BN6MB18 |
0.03% | ACIU | AC IMMUNE SA | -- | $23,564.43 | 6,089 | BZC0D70 |
0.03% | FULC | FULCRUM THERAPEUTICS INC | -- | $23,399.60 | 3,836 | BJDX8Z9 |
0.03% | PGEN | PRECIGEN INC | -- | $23,217.18 | 15,582 | BKM5C84 |
0.03% | EDIT | EDITAS MEDICINE INC | -- | $23,045.04 | 5,076 | BZ8FPH3 |
0.03% | CABA | CABALETTA BIO INC | -- | $22,022.20 | 2,980 | BK5MWR1 |
0.03% | AVXL | ANAVEX LIFE SCIENCES CORP | -- | $21,575.12 | 5,224 | BYTYP72 |
0.03% | PACB | PACIFIC BIOSCIENCES OF CALIF | -- | $21,520.64 | 16,813 | B4N8MH9 |
0.02% | PAHC | PHIBRO ANIMAL HEALTH CORP-A | -- | $20,958.50 | 1,255 | BL95N25 |
0.02% | TRML | TOURMALINE BIO INC | -- | $19,866.65 | 1,583 | BQ80NC6 |
0.02% | VNDA | VANDA PHARMACEUTICALS INC | -- | $18,929.84 | 3,592 | B12W3P6 |
0.02% | XERS | XERIS BIOPHARMA HOLDINGS INC | -- | $18,851.06 | 9,151 | BLR7H87 |
0.02% | ALXO | ALX ONCOLOGY HOLDINGS INC | -- | $18,389.80 | 3,215 | BLN7XQ1 |
0.02% | NAUT | NAUTILUS BIOTECHNOLOGY INC | -- | $17,551.64 | 7,732 | BNG1NK8 |
0.02% | AMRN | AMARIN CORP PLC -ADR | -- | $17,507.97 | 24,834 | 2301938 |
0.02% | AVIR | ATEA PHARMACEUTICALS INC | -- | $16,789.54 | 5,198 | BLN9Z50 |
0.02% | MGNX | MACROGENICS INC | -- | $15,850.60 | 3,866 | BFDV8K0 |
0.02% | ZNTL | ZENTALIS PHARMACEUTICALS INC | -- | $15,647.31 | 4,383 | BMQ5T49 |
0.02% | MGTX | MEIRAGTX HOLDINGS PLC | -- | $15,637.86 | 3,969 | BFYQFJ2 |
0.02% | RVNC | REVANCE THERAPEUTICS INC | -- | $15,572.70 | 6,435 | BJFSR99 |
0.02% | EXAI | EXSCIENTIA PLC | -- | $15,417.30 | 3,023 | BP48134 |
0.02% | ATAI | ATAI LIFE SCIENCES NV | -- | $13,432.90 | 10,333 | BN6M8F1 |
0.01% | QURE | UNIQURE NV | -- | $12,013.96 | 2,996 | BJFSR88 |
0.01% | BLUE | BLUEBIRD BIO INC | -- | $10,846.43 | 11,750 | BBFL7S1 |
0.01% | CHRS | COHERUS BIOSCIENCES INC | -- | $9,843.98 | 7,082 | BRK0149 |
0.01% | BMEA | BIOMEA FUSION INC | -- | $9,808.02 | 2,214 | BNKF6N0 |
0.01% | VTYX | VENTYX BIOSCIENCES INC | -- | $9,311.14 | 4,351 | BMG99Y1 |
0.01% | CRBU | CARIBOU BIOSCIENCES INC | -- | $8,920.00 | 5,575 | BNYJR68 |
0.01% | ME | 23ANDME HOLDING CO -CLASS A | -- | $7,825.03 | 19,972 | BM9CKX3 |
0.01% | AMLX | AMYLYX PHARMACEUTICALS INC | -- | $7,302.78 | 4,197 | BPCK358 |
0.01% | RAPT | RAPT THERAPEUTICS INC | -- | $6,009.66 | 2,154 | BK5T6R0 |
0.01% | ACRS | ACLARIS THERAPEUTICS INC | -- | $5,013.72 | 4,398 | BYV2W40 |
-- | MRNS | MARINUS PHARMACEUTICALS INC | -- | $4,035.29 | 3,391 | BM8MVZ3 |
-- | OVID | OVID THERAPEUTICS INC | -- | $3,386.72 | 4,379 | BYPFK63 |
-- | RPHM | RENEO PHARMACEUTICALS INC | -- | $3,115.13 | 2,063 | BMHR7T5 |
-- | 2324462D | CARTESIAN THERAPEUTICS-CVR | -- | $1,761.30 | 9,785 | BM9HFX3 |
-- | -- | TREASURY BILL | -- | $14,921,235.00 | 15,000,000 | BRYQ9Y9 |
-- | -- | NET OTHER ASSETS (LIABILITIES) | -- | $10,550,809.43 | 10,550,809 | -- |
Index
as of 3/28/2024
- Total Number of Companies218
- Price/Earnings Ratio--
- Price/Book Ratio4.157
- Dividend Yield ( % )0.88
- Avg. Index Market Capitalization$6.77 billion
About the Index
The Nasdaq Biotechnology Index is a modified capitalization weighted index that includes securities of The Nasdaq Stock Market listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by The Nasdaq OMX Group, Inc., including minimum market capitalization and liquidity requirements.
Distributions
For
- 2024
- 2023
- 2022
Ex-Dividend Date | Record Date | Payable Date | Dividend | Long-Term Capital Gain | Short-Term Capital Gain | Return of Capital |
---|